THBS1 and thrombotic disease: Future studies should shed light on the contribution of thrombospondin-1 in platelet activation and thrombus formation; in fact, targeting the thrombospondin-1 pathway may represent a promising thrombolytic strategy for controlling platelet activation in thrombotic diseases.